Advanced Therapies Europe 2025

Advanced Therapies Europe 2025 will take place from September 2 to 4, 2025, at the Hotel Arts Barcelona (Spain) and will be organized by Phacilitate.

They join 500 of the most influential minds in cell and gene therapy for a high-impact, curated experience in Barcelona — one of Europe’s fastest-growing biotech hubs. Across three days of expert content, strategic networking, and invite-only summits, Advanced Therapies Europe 2025 connects therapeutic developers, pharma leaders, CDMOs, and investors in one focused environment.

From plenary sessions and technical workshops to the Women in Advanced Therapies Congress and Investment Summit, every element is designed to accelerate innovation, investment, and commercialisation across the advanced therapies landscape.

Whether you're launching a new therapy, seeking strategic partnerships, or staying ahead of regulatory and market shifts, Advanced Therapies Europe is built to deliver actionable insight and meaningful connections.

• Expand Your Network – Meet biotech CEOs, pharma strategists, CDMO leaders, and investors shaping the next wave of therapeutic innovation.
   
• Gain Strategic Insight – Access sessions led by industry experts on regulation, funding trends, scale-up solutions, and commercial strategy.
   
• Discover What’s Next – Explore the latest advances in cell and gene therapy platforms, biotech technologies, and regenerative medicine.

Ahead of Phacilitate’s Advanced Therapies Europe, they join key industry experts to discuss the current state and trajectory of ATMPs in the EU.

As the world has seen seismic shifts in the funding, technical, and commercial landscape for cell and gene therapies, they recognize the importance of identifying Europe’s evolving role in the global ecosystem, and how they can establish and shore up European bioregions that can translate, develop, and manufacture the next generation of ATMPs.

This is a must-attend, plenary-level meeting for translational, technical, and commercial cell and gene therapy experts.

When?
Thursday, July 10, 2025 · 1:30 p.m.

Speakers:

• Lindsay Davies, CEO. NextCell
• Miguel Forte, CEO. Kiji Therapeutics
• Montse Daban, Director of Science Policy & Internalization. Biocat

Fireside chat: From Seed to scale – How we built an investor-ready biotech

A candid conversation between a biotech founder and their early investor exploring the startup journey.

02/09/2025

10:50 AM - 11:20 AM

Hotel Arts, Barcelona (Spain)

Speakers:

• Sylvain Sachot, Partner. Asabys Partners
• Miquel Vila-Perelló, CEO. Splice Bio
   

Panel: Trends talk – Emerging hotspots in biotech investing

A rapid-fire panel / multi-perspective session on high-growth areas in biotech. Each speaker gives a 5-minute outlook on where their focus and how this aligns with market trends.

02/09/2025

12:10 AM - 12:50 AM

Hotel Arts, Barcelona (Spain)

Speakers:

• Artemy Shumisky, Senior Associate. LongeVC
• Luis Pareras, Managing Partner. Invivo Partners
• Ilya Yasny, Partner. LanceBio Ventures
   

Opening Panel: Rethinking access and advancement within the advanced therapies industry

Explore the complex mix of visible and invisible barriers that shape entry into the industry. Address systemic challenges and how we can create a truly inclusive workforce.

02/09/2025

2:05 PM - 2:45 PM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Terri Gaskell, CTO. Rinri Therapeutics

Speakers:

• Avencia Sanchez-Mejias, CEO & Co-founder. Integra Therapeutics
• Keren Leshem, CEO & Interim Chair. OCON Therapeutics
• Kat Kozyrytska, Founder. Cell Therapy Manufacturability Program
• Mayra Battilani, Former EMEA – Commercial Strategy Director Gene Therapy – Rare Diseases. Johnson & Johnson
   

Roundtable 5: How to be a good mentor – and find one

02/09/2025

3:25 PM - 4:10 PM

Hotel Arts, Barcelona (Spain)

Speakers:

• Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform. Hospital Sant Joan de Déu
• Anne Douar, Director and Founder. Ad hoc Biologics
• Mayra Battilani, Former Director of Commercial Strategy for EMEA, Gene Therapy and Rare Diseases. Johnson & Johnson
• Keren Leshem, CEO and Interim President. OCON Therapeutics.
   

Panel: The state of the CGT industry & turning the future into action 

This session will explore the current state of the CGT industry, with a focus on Europe’s evolving role amid global shifts. In a climate where research ecosystems face mounting uncertainty — particularly following moves in the U.S. to scale back federal support for scientific innovation, Europe must sharpen its competitiveness to secure its leadership in advanced therapies. 

03/09/2025

9:10 AM - 9:55 AM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Anthony Davies, Founder & CEO. Dark Horse Consulting

Speakers:

• Thomas Carlsen, CEO. Novo Nordisk Cellerator
• Marion Hitchcock, Managing Director Gene & Cell Therapies Incubator Berlin. Bayer
• Claire Skentelbery, CEO. EuropaBio
• Montse Daban, Strategic Foresight and International Relations Director. Biocat

Panel: Is decentralized manufacturing the path to profitability?

Analyzes the economic realities behind the trend toward decentralization.

09/03/2025

11:00 AM – 11:40 AM

Hotel Arts, Barcelona (Spain)

Moderator:

• Montse Daban, Director of Strategic Analysis and International Relations. Biocat

Speakers:

• Noelia Mateo, Global Director of Advanced Therapies, Business and Strategy. Hospital Clínic de Barcelona

Spain’s Biotech Leap: Manufacturing, Clinical Capacity & EU Integration

Explore Spain’s growing potential as a strategic ATMP manufacturing and clinical trial hub within the EU.

03/09/2025

12:20 AM - 1 PM

Hotel Arts, Barcelona (Spain)

Speakers:

• Montse Daban, Strategic Foresight and International Relations Director. Biocat
• Gerard Caelles, Chief Business Officer. SpliceBio
• Stefanos Theoharis, Chief Executive Officer. OneChain Therapeutics
• Claudio Santos, CEO. Gyala Therapeutics
   

Panel: From discovery to development – Creating realistic CGT timelines

The transition from academic scientific concept to market-ready product requires biotech teams to integrate CMC, regulatory, and pharmacology considerations from the outset, thereby avoiding the pitfalls of overselling and overpromising.

03/09/2025

2:00 PM - 2:35 PM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Elena Matsa, Professor. University College Cork

Speakers:

• Anne Douar, Principal & Founder. Ad hoc Biologics
• John Campbell, CSO. Swarm Oncology
• Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform. Hospital Sant Joan de Déu
• Claudio Santos, CEO. Gyala Therapeutics

Innovation exchange

Join us for an exciting session where innovative biotech start-ups pitch their groundbreaking ideas and solutions. Watch as they present to a panel of expert investors, who will provide real-time feedback, insights, and guidance. This is a unique opportunity to explore cutting-edge advancements in the biotech space and gain valuable perspectives from both entrepreneurs and industry leaders. 

04/09/2025

9:00 AM - 10:30 AM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Nathan Cox,  Account Manager. Medicpres

Speakers:

• Sven Kili, Partner. Saisei Ventures
• Rahul Khetan, Venture Associate. UCB Ventures
• Laura Rodriguez Gallego, Partner. Invivo Partners
• Malgorzata Rogalska, Analyst. Ysios Capital
   

Panel: Charting the way forward: Where are we heading?

As we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed. 

04/09/2025

3 PM - 3:35 PM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Montse Daban, Strategic Foresight and International Relations Director. Biocat

Speakers:

• Angela Vollstedt, Director Global Cell & Gene Therapies Portfolio. Novartis
• Miguel Forte, Chief Executive Officer & President, ISCT. Kiji Therapeutics
• Raphael Ognar,  Chief Executive Officer. NKILT Therapeutics

20% discount for companies and organizations in the BioRegion of Catalonia using the code BIOCAT20 at registration